PubRank

Andrej Tarkowski

Author PubWeight™ 88.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005 3.63
2 The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 2007 2.27
3 Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol 2004 2.17
4 High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum 2003 1.93
5 Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J Bacteriol 2006 1.86
6 Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 2004 1.80
7 Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 2003 1.65
8 Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging 2002 1.56
9 Complement deficiency ameliorates collagen-induced arthritis in mice. J Immunol 2002 1.51
10 Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis 2008 1.48
11 GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J Clin Invest 2007 1.47
12 Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 2005 1.43
13 Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One 2006 1.38
14 Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus. J Bacteriol 2007 1.34
15 Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Arthritis Res Ther 2009 1.26
16 Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1. Arthritis Rheum 2006 1.24
17 The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One 2009 1.19
18 Identification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS One 2008 1.19
19 Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci U S A 2006 1.18
20 Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One 2008 1.14
21 Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection. J Immunol 2002 1.09
22 Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol 2005 1.08
23 Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther 2008 1.08
24 Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. J Rheumatol 2008 1.05
25 Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther 2005 1.05
26 Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus. Infect Immun 2007 1.04
27 Tissue factor as a proinflammatory agent. Arthritis Res 2002 1.04
28 Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. Microbiology 2009 1.02
29 Phenotypic and functional characterization of human CD25+ B cells. Immunology 2006 1.02
30 Arthritogenic properties of double-stranded (viral) RNA. J Immunol 2004 1.01
31 Identification of an intracellular M17 family leucine aminopeptidase that is required for virulence in Staphylococcus aureus. Microbes Infect 2012 0.99
32 Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol 2003 0.99
33 Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther 2003 0.97
34 T-box transcription-factor-deficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis. Microbes Infect 2004 0.96
35 Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim Biophys Acta 2009 0.95
36 Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res Ther 2009 0.93
37 Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis. PLoS One 2008 0.92
38 The impact of Fcgamma receptors on Staphylococcus aureus infection. Microb Pathog 2002 0.92
39 Smoking and nicotine exposure delay development of collagen-induced arthritis in mice. Arthritis Res Ther 2009 0.91
40 Survivin is an essential mediator of arthritis interacting with urokinase signalling. J Cell Mol Med 2009 0.91
41 Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol 2007 0.91
42 Phytoestrogen genistein as an anti-staphylococcal agent. Microbes Infect 2004 0.90
43 Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis. Ann Med 2010 0.89
44 Cerebral inflammation and degeneration in systemic lupus erythematosus. Curr Opin Rheumatol 2004 0.88
45 The peptide AF-16 abolishes sickness and death at experimental encephalitis by reducing increase of intracranial pressure. Brain Res 2008 0.86
46 Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern. J Leukoc Biol 2007 0.86
47 Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis. J Rheumatol 2003 0.86
48 Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis. Arthritis Rheum 2009 0.86
49 Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis. J Leukoc Biol 2005 0.85
50 Anti-staphylococcal activities of lysostaphin and LytM catalytic domain. BMC Microbiol 2012 0.85
51 Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis. Arthritis Res Ther 2002 0.84
52 In vivo sortase A and clumping factor A mRNA expression during Staphylococcus aureus infection. Microb Pathog 2007 0.84
53 Arthritogenic dsRNA is present in synovial fluid from rheumatoid arthritis patients with an erosive disease course. Eur J Immunol 2008 0.84
54 Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes Infect 2004 0.84
55 Salivary resistin reflects local inflammation in Sjögren's syndrome. J Rheumatol 2008 0.83
56 Human alpha -defensins neutralize fibrinolytic activity exerted by staphylokinase. Thromb Haemost 2004 0.83
57 The presence of local and circulating autoreactive B cells in patients with advanced periodontitis. J Clin Periodontol 2002 0.83
58 mgrA regulates staphylococcal virulence important for induction and progression of septic arthritis and sepsis. Microbes Infect 2008 0.82
59 Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Arthritis Res Ther 2004 0.82
60 Inflammatogenic properties of bacterial DNA following cutaneous exposure. J Invest Dermatol 2003 0.82
61 Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. Scand J Infect Dis 2010 0.82
62 Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Res Ther 2004 0.82
63 Requirement of type I interferon signaling for arthritis triggered by double-stranded RNA. Arthritis Rheum 2006 0.82
64 Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis. Microbes Infect 2006 0.81
65 Rapid systemic bone resorption during the course of Staphylococcus aureus-induced arthritis. J Infect Dis 2006 0.81
66 Staphylokinase reduces plasmin formation by endogenous plasminogen activators. Eur J Haematol 2008 0.81
67 Single-stranded polyinosinic acid oligonucleotides trigger leukocyte production of proteins belonging to fibrinolytic and coagulation cascades. J Leukoc Biol 2008 0.81
68 Formylated peptides are important virulence factors in Staphylococcus aureus arthritis in mice. J Infect Dis 2011 0.81
69 Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol 2004 0.81
70 Urokinase-type plasminogen activator, an endogenous antibiotic. J Infect Dis 2005 0.80
71 Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. J Rheumatol 2005 0.80
72 The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs. Inflammation 2004 0.80
73 Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. J Orthop Res 2007 0.80
74 Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock. Infect Immun 2002 0.80
75 RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. Bone 2009 0.79
76 Induction of arthritis by high mobility group box chromosomal protein 1 is independent of tumour necrosis factor signalling. Arthritis Res Ther 2008 0.79
77 The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus. Int Immunopharmacol 2004 0.79
78 Immunostimulatory DNA induces degranulation and NADPH-oxidase activation in human neutrophils while concomitantly inhibiting chemotaxis and phagocytosis. Eur J Immunol 2002 0.78
79 Identification of conserved antigens from staphylococcal and streptococcal pathogens. J Med Microbiol 2012 0.78
80 Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis. Arthritis Res Ther 2005 0.78
81 The role of B cell CD22 expression in Staphylococcus aureus arthritis and sepsis. Microbes Infect 2004 0.77
82 The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Rheumatology (Oxford) 2009 0.77
83 Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2009 0.76
84 Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodies. FEMS Immunol Med Microbiol 2008 0.76
85 Synergistic action of immunostimulatory DNA and fcgamma receptor IIB-crosslinking on B-cell phenotype and function. Immunobiology 2005 0.75
86 Polarization of cytokine responses in B- and T-lymphocytes during Staphylococcus aureus infection. Microb Pathog 2003 0.75
87 Anti-proliferative effects of phosphodiester oligodeoxynucleotides. Immunobiology 2004 0.75
88 Phosphorotioated oligonucleotides trigger synthesis of human coagulation serine proteases. Thromb Haemost 2002 0.75
89 The role of urokinase in innate immunity against Staphylococcus aureus. Microbes Infect 2005 0.75
90 Impact of site-specific nucleobase deletions on the arthritogenicity of DNA. Inflammation 2004 0.75